Lv2
110 积分 2022-12-03 加入
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)
22天前
已完结
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Zanubrutinib in Immune Thrombocytopenia
26天前
已完结
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
28天前
已完结
Bintrafusp alfa versus pembrolizumab in patients with PD-L1-positive advanced non-small-cell lung cancer resistant to platinum-containing chemotherapy: a multicentre, open-label, randomised, phase 2 study
1个月前
已关闭
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
1个月前
已完结
Targeting SIRT2 induces MLH1 deficiency and boosts antitumor immunity in preclinical colorectal cancer models
1个月前
已完结
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types
1个月前
已完结
Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions
1个月前
已完结
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma
1个月前
已完结
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy
2个月前
已完结
皖公网安备34019202002308
